Literature DB >> 3053874

Metastatic septic endophthalmitis in pyogenic liver abscess.

C T Chiu1, D Y Lin, Y F Liaw.   

Abstract

In a consecutive series of 180 patients with pyogenic liver abscess, three patients (two men and one woman, between 46 and 75 years of age) had metastatic Klebsiella endophthalmitis. The incidence of metastatic endophthalmitis was 1.7% in patients with pyogenic liver abscess, 5.2% in patients with Klebsiella liver abscess, and 7.8% in patients with Klebsiella liver abscess having Klebsiella bacteremia. Despite aggressive therapeutic measures, the men permanently lost their vision and the woman eventually required an evisceration of her right eye. Delayed recognition and/or treatment as well as the nature of bacteria probably contributed to the tragic outcome. The findings suggest that a high index of suspicion is critical and a combined effort of the internist and ophthalmologist is mandatory.

Entities:  

Mesh:

Year:  1988        PMID: 3053874     DOI: 10.1097/00004836-198810000-00009

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  21 in total

Review 1.  The microbiology of endophthalmitis: global trends and a local perspective.

Authors:  Y Keynan; Y Finkelman; P Lagacé-Wiens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-05       Impact factor: 3.267

2.  Isolation of a chromosomal region of Klebsiella pneumoniae associated with allantoin metabolism and liver infection.

Authors:  Huei-Chi Chou; Cha-Ze Lee; Li-Chen Ma; Chi-Tai Fang; Shan-Chwen Chang; Jin-Town Wang
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

Review 3.  Hypervirulence and hypermucoviscosity: Two different but complementary Klebsiella spp. phenotypes?

Authors:  Juan Carlos Catalán-Nájera; Ulises Garza-Ramos; Humberto Barrios-Camacho
Journal:  Virulence       Date:  2017-04-12       Impact factor: 5.882

4.  Clinical review of endogenous endophthalmitis in Korea: a 14-year review of culture positive cases of two large hospitals.

Authors:  Kyu Sik Chung; Young Keun Kim; Young Goo Song; Chang Oh Kim; Sang Hoon Han; Bum Sik Chin; Nam Su Gu; Su Jin Jeong; Ji-Hyeon Baek; Jun Yong Choi; Hyo Youl Kim; June Myung Kim
Journal:  Yonsei Med J       Date:  2011-07       Impact factor: 2.759

5.  Contribution of mucoviscosity-associated gene A (magA) to virulence in experimental Klebsiella pneumoniae endophthalmitis.

Authors:  Jonathan J Hunt; Jin-Town Wang; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-29       Impact factor: 4.799

6.  Characterization of integrative and conjugative element ICEKp1-associated genomic heterogeneity in a Klebsiella pneumoniae strain isolated from a primary liver abscess.

Authors:  Tzu-Lung Lin; Cha-Ze Lee; Pei-Fang Hsieh; Shih-Feng Tsai; Jin-Town Wang
Journal:  J Bacteriol       Date:  2007-11-02       Impact factor: 3.490

Review 7.  Review of hepatic abscess from Klebsiella pneumoniae. An association with diabetes mellitus and septic endophthalmitis.

Authors:  S H Han
Journal:  West J Med       Date:  1995-03

8.  The Klebsiella pneumoniae YfgL (BamB) lipoprotein contributes to outer membrane protein biogenesis, type-1 fimbriae expression, anti-phagocytosis, and in vivo virulence.

Authors:  Pei-Fang Hsieh; Chun-Ru Hsu; Chun-Tang Chen; Tzu-Lung Lin; Jin-Town Wang
Journal:  Virulence       Date:  2016-03-30       Impact factor: 5.882

9.  Humoral immunity against capsule polysaccharide protects the host from magA+ Klebsiella pneumoniae-induced lethal disease by evading Toll-like receptor 4 signaling.

Authors:  Ming-Fang Wu; Chih-Ya Yang; Tzu-Lung Lin; Jin-Town Wang; Feng-Ling Yang; Shih-Hsiung Wu; Bor-Shen Hu; Teh-Ying Chou; Ming-Daw Tsai; Chi-Hung Lin; Shie-Liang Hsieh
Journal:  Infect Immun       Date:  2008-11-17       Impact factor: 3.441

10.  Extended-spectrum cephalosporin compared to cefazolin for treatment of Klebsiella pneumoniae-caused liver abscess.

Authors:  Hsiao-Pei Cheng; L K Siu; Feng-Yee Chang
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.